Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Kikuchi, Ryutaro ^a   Sonobe, Makoto ^a   Kobayashi, Masashi ^a   Ishikawa, Masashi ^a   Kitamura, Jiro ^a   Nakayama, Ei ^a   Menju, Toshi ^a   Miyahara, Ryo ^a   Huang, Cheng Long ^a   Date, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENES, NEOPLASM; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84865047534     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1878-x     Document Type: Article

References (37)

1. H Asamura T Goya Y Koshiishi, et al. 2008 A Japanese Lung Cancer Registry study: prognosis of 13, 010 resected lung cancers J Thorac Oncol. 3 46 52 18166840 10.1097/JTO.0b013e31815e8577
2. M Maemondo A Inoue K Kobayashi, et al. 2010 Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med. 362 2380 2388 20573926 10.1056/NEJMoa0909530 1:CAS:528:DC%2BC3cXot1Gjt7Y%3D
3. A Sandler R Gray MC Perry, et al. 2006 Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med. 355 2542 2550 17167137 10.1056/NEJMoa061884 1:CAS:528:DC%2BD28XhtlWqsbzI
4. M Pollak 2008 Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer. 8 915 928 19029956 10.1038/nrc2536 1:CAS:528:DC%2BD1cXhsVWhu7rL
5. MM Chitnis JS Yuen AS Protheroe M Pollak VM Macaulay 2008 The type 1 insulin-like growth factor receptor pathway Clin Cancer Res. 14 6364 6370 18927274 10.1158/1078-0432.CCR-07-4879 1:CAS:528:DC%2BD1cXht1KgtbrP
6. A Imsumran Y Adachi H Yamamoto, et al. 2007 Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma Carcinogenesis. 28 947 956 17183068 10.1093/carcin/ bgl247 1:CAS:528:DC%2BD2sXlvFGls7c%3D
7. J Matsubara Y Yamada Y Hirashima, et al. 2008 Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer Clin Cancer Res. 14 3022 3029 18483367 10.1158/1078-0432.CCR-07-1898 1:CAS:528:DC%2BD1cXmtVCmtLc%3D
8. D Takahari Y Yamada NT Okita, et al. 2009 Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer Oncology. 76 42 48 19033715 10.1159/000178164 1:CAS:528:DC%2BD1cXhsFarsbbO
9. AS Parker JC Cheville CA Janney JR Cerhan 2002 High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas Hum Pathol. 33 801 805 12203212 10.1053/hupa.2002.126186 1:CAS:528:DC%2BD38XnsFSjsLs%3D
10. YF Huang MR Shen KF Hsu YM Cheng CY Chou 2008 Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer Br J Cancer. 99 1096 1102 18781172 10.1038/sj.bjc.6604661 1:CAS:528:DC%2BD1cXhtFyqt7vO
11. J van der Veeken S Oliveira RM Schiffelers G Storm H van Bergen PM Enenegouwen RC Roovers 2009 Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy Curr Cancer Drug Targets. 9 748 760 19754359 10.2174/156800909789271495
12. M Guix AC Faber SE Wang, et al. 2008 Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins J Clin Invest. 118 2609 2619 18568074 1:CAS:528:DC%2BD1cXot1Onurk%3D
13. AK Chakraborty K Liang MP DiGiovanna 2008 Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer Cancer Res. 68 1538 1545 18316619 10.1158/0008-5472.CAN-07-5935 1:CAS:528:DC%2BD1cXislansr8%3D
14. F Morgillo WY Kim ES Kim F Ciardiello WK Hong HY Lee 2007 Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib Clin Cancer Res. 13 2795 2803 17473213 10.1158/1078-0432.CCR-06-2077 1:CAS:528:DC%2BD2sXkslOhu7o%3D
15. A Chakravarti JS Loeffler NJ Dyson 2002 Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling Cancer Res. 62 200 207 11782378 1:CAS:528:DC%2BD38XntV2hsA%3D%3D
16. Hurbin A, Wislez M, Busser B, et al. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma. J Pathol. 2011. doi: 10.1002/path.2897.
17. F Morgillo JK Woo ES Kim WK Hong HY Lee 2006 Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib Cancer Res. 66 10100 10111 17047074 10.1158/0008-5472.CAN-06-1684 1:CAS:528:DC%2BD28XhtVyiur7F
18. V Ludovini G Bellezza L Pistola, et al. 2009 High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients Ann Oncol. 20 842 849 19153117 10.1093/annonc/mdn727 1:STN:280:DC%2BD1MzgvVyhtg%3D%3D
19. F Cappuzzo G Tallini G Finocchiaro, et al. 2010 Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients Ann Oncol. 21 562 567 19767315 10.1093/annonc/mdp357 1:STN:280:DC%2BC3c7isVGmtg%3D%3D
20. R Dziadziuszko DT Merrick SE Witta, et al. 2010 Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression J Clin Oncol. 28 2174 2180 20351332 10.1200/JCO.2009.24.6611
21. P Goldstraw J Crowley K Chansky, et al. 2007 The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol. 2 706 714 17762336 10.1097/JTO.0b013e31812f3c1a
22. Travis WD, Brambillia E, Müller-Hermelink HK, Haris CC. Tumors of the lung, pleura, thymus and heart. In: Kleihues P, Sobin LH, editors. World Health Organization classification of tumours, Edition Lyon: IARC; 2004.
23. X Liu T Turbyville A Fritz L Whitesell 1998 Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice Cancer Res. 58 5432 5438 9850076 1:CAS:528:DyaK1cXotVWjs70%3D
24. GW Allen C Saba EA Armstrong, et al. 2007 Insulin-like growth factor-I receptor signaling blockade combined with radiation Cancer Res. 67 1155 1162 17283150 10.1158/0008-5472.CAN-06-2000 1:CAS:528:DC%2BD2sXht1ynsLY%3D
25. SE Dunn M Ehrlich NJ Sharp, et al. 1998 A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer Cancer Res. 58 3353 3361 9699666 1:CAS:528:DyaK1cXltFyisr0%3D
26. D Sachdev JS Hartell AV Lee X Zhang D Yee 2004 A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells J Biol Chem. 279 5017 5024 14615489 10.1074/jbc.M305403200 1:CAS:528: DC%2BD2cXpslSitw%3D%3D
27. D Sachdev X Zhang I Matise M Gaillard-Kelly D Yee 2010 The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival Oncogene. 29 251 262 19838209 10.1038/onc.2009.316 1:CAS:528:DC%2BD1MXht1Ogsr%2FL
28. M Nakamura S Miyamoto H Maeda, et al. 2004 Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers Clin Cancer Res. 10 8434 8441 15623623 10.1158/1078-0432.CCR-04-0430 1:CAS:528:DC%2BD2cXhtFGjs73F
29. P Kornprat P Rehak J Ruschoff C Langner 2006 Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours J Clin Pathol. 59 202 206 16443739 10.1136/jcp.2005.028480 1:CAS:528:DC%2BD28XhvV2nsrk%3D
30. J Ahlen J Wejde O Brosjo, et al. 2005 Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma Clin Cancer Res. 11 206 216 15671548 1:CAS:528:DC%2BD2MXhtVegsLo%3D
31. BW Sutherland SE Knoblaugh PJ Kaplan-Lefko F Wang M Holzenberger NM Greenberg 2008 Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium Cancer Res. 68 3495 3504 18451178 10.1158/0008-5472.CAN-07- 6531 1:CAS:528:DC%2BD1cXltlSltL8%3D
32. J Dupont M Holzenberger 2003 Biology of insulin-like growth factors in development Birth Defects Res C Embryo Today. 69 257 271 14745968 10.1002/bdrc.10022 1:CAS:528:DC%2BD2cXlvFSmug%3D%3D
33. VC Russo PD Gluckman EL Feldman GA Werther 2005 The insulin-like growth factor system and its pleiotropic functions in brain Endocr Rev. 26 916 943 16131630 10.1210/er.2004-0024 1:CAS:528:DC%2BD28XktVygtA%3D%3D
34. PG Laustsen SJ Russell L Cui, et al. 2007 Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function Mol Cell Biol. 27 1649 1664 17189427 10.1128/MCB.01110-06 1:CAS:528:DC%2BD2sXit1WgtLc%3D
35. B Schnarr K Strunz J Ohsam A Benner J Wacker D Mayer 2000 Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer Int J Cancer. 89 506 513 11102895 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F 1:CAS:528:DC%2BD3cXptVejs74%3D
36. AS Allison MA McIntyre C McArdle FK Habib 2007 The insulin-like growth factor type 1 receptor and colorectal neoplasia: insights into invasion Hum Pathol. 38 1590 1602 17651787 10.1016/j.humpath.2007.03.013 1:CAS:528: DC%2BD2sXhtF2lsb3N
37. Y Ichinose T Yano H Asoh H Yokoyama I Yoshino Y Katsuda 1995 Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage J Thorac Cardiovasc Surg. 110 601 605 7564425 10.1016/S0022-5223(95)70090-0 1:STN:280:DyaK28%2FgsVOjtQ%3D%3D